Marjan Bouma

568 total citations
20 papers, 447 citations indexed

About

Marjan Bouma is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marjan Bouma has authored 20 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Biomaterials and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marjan Bouma's work include Nanoparticle-Based Drug Delivery (5 papers), Chemical Synthesis and Analysis (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Marjan Bouma is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Chemical Synthesis and Analysis (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Marjan Bouma collaborates with scholars based in Netherlands, Spain and Italy. Marjan Bouma's co-authors include Bastiaan Nuijen, Jos H. Beijnen, A. Bult, Paolo Enrico, Ben H.C. Westerink, Jan H.M. Schellens, Gianni Sava, José Jimeno, A. Bult and J. H. Beijnen and has published in prestigious journals such as Brain Research, International Journal of Pharmaceutics and British Journal of Clinical Pharmacology.

In The Last Decade

Marjan Bouma

20 papers receiving 423 citations

Peers

Marjan Bouma
Pieter H.J. Houba Netherlands
R. Spinelli Italy
István Kertész Hungary
Daniel Gündel Germany
Ruth Goldschmidt United States
Claudia Rosenbaum Germany
Ole Tietz United Kingdom
Margaréta Lantow Germany
Vikas V. Dukhande United States
Chunyang Jin United States
Pieter H.J. Houba Netherlands
Marjan Bouma
Citations per year, relative to Marjan Bouma Marjan Bouma (= 1×) peers Pieter H.J. Houba

Countries citing papers authored by Marjan Bouma

Since Specialization
Citations

This map shows the geographic impact of Marjan Bouma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjan Bouma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjan Bouma more than expected).

Fields of papers citing papers by Marjan Bouma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjan Bouma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjan Bouma. The network helps show where Marjan Bouma may publish in the future.

Co-authorship network of co-authors of Marjan Bouma

This figure shows the co-authorship network connecting the top 25 collaborators of Marjan Bouma. A scholar is included among the top collaborators of Marjan Bouma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjan Bouma. Marjan Bouma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riphagen, Ineke J., et al.. (2022). Case report: Salicylate intoxication can present with a normal anion gap metabolic acidosis depending on method used for measuring chloride. British Journal of Clinical Pharmacology. 88(11). 4933–4936. 2 indexed citations
2.
Grijseels, E. W. M., et al.. (2003). NHG-Standaard Acuut coronair syndroom (Acuut myocardinfarct en instabiele angina pectoris). Huisarts en Wetenschap. 46(14). 831–843. 1 indexed citations
3.
Bouma, Marjan, et al.. (2003). Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A. Journal of Pharmaceutical and Biomedical Analysis. 31(2). 215–228. 14 indexed citations
4.
Bouma, Marjan, Bastiaan Nuijen, J R Rice, et al.. (2003). Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Investigational Polymer-Conjugated Platinum Anticancer Agent AP 5280. Drug Development and Industrial Pharmacy. 29(9). 981–995. 8 indexed citations
5.
Bouma, Marjan, Bastiaan Nuijen, Donald R. Stewart, et al.. (2003). Pharmaceutical quality control of the investigational polymer-conjugated platinum anticancer agent AP 5280.. PubMed. 57(3). 198–207. 7 indexed citations
6.
Bouma, Marjan, Bastiaan Nuijen, Gianni Sava, et al.. (2002). Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A. International Journal of Pharmaceutics. 248(1-2). 247–259. 13 indexed citations
7.
8.
Bouma, Marjan, et al.. (2002). Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A. Journal of Pharmaceutical and Biomedical Analysis. 30(4). 1287–1296. 19 indexed citations
9.
Bouma, Marjan, et al.. (2002). A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A. International Journal of Pharmaceutics. 248(1-2). 239–246. 59 indexed citations
10.
Nuijen, Bastiaan, Marjan Bouma, Jan H.M. Schellens, & Jos H. Beijnen. (2001). Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes. Investigational New Drugs. 19(2). 143–153. 81 indexed citations
11.
Nuijen, Bastiaan, Marjan Bouma, H. Talsma, et al.. (2001). Development of a Lyophilized Parenteral Pharmaceutical Formulation of the Investigational Polypeptide Marine Anticancer Agent Kahalalide F. Drug Development and Industrial Pharmacy. 27(8). 767–780. 13 indexed citations
12.
Nuijen, Bastiaan, Marjan Bouma, José Jimeno, et al.. (2001). Compatibility and Stability of the Investigational Polypeptide Marine Anticancer Agent Kahalalide F in Infusion Devices. Investigational New Drugs. 19(4). 273–281. 11 indexed citations
13.
Nuijen, Bastiaan, et al.. (2001). HPLC-UV METHOD DEVELOPMENT AND IMPURITY PROFILING OF THE MARINE ANTICANCER AGENT APLIDINE IN RAW DRUG SUBSTANCE AND PHARMACEUTICAL DOSAGE FORM. Journal of Liquid Chromatography & Related Technologies. 24(20). 3119–3139. 4 indexed citations
14.
Nuijen, Bastiaan, Marjan Bouma, Hilde Rosing, et al.. (2001). DEVELOPMENT OF AN HPLC METHOD WITH UV DETECTION FOR THE PHARMACEUTICAL QUALITY CONTROL OF THE NOVEL MARINE ANTICANCER AGENT KAHALALIDE F. Journal of Liquid Chromatography & Related Technologies. 24(20). 3141–3155. 3 indexed citations
15.
Nuijen, Bastiaan, et al.. (2001). In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol.. PubMed. 55(4). 223–9. 8 indexed citations
16.
Nuijen, Bastiaan, Marjan Bouma, R.E.C. Henrar, et al.. (2000). In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BS. International Journal of Pharmaceutics. 194(2). 261–267. 13 indexed citations
17.
Nuijen, Bastiaan, Marjan Bouma, José Jimeno, et al.. (2000). Pharmaceutical development of anticancer agents derived from marine sources. Anti-Cancer Drugs. 11(10). 793–811. 52 indexed citations
18.
Nuijen, Bastiaan, Marjan Bouma, R.E.C. Henrar, et al.. (2000). Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.. PubMed. 54(3). 193–208. 24 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter H.J. Houba Breakdown of academic impact, for papers by R. Spinelli Breakdown of academic impact, for papers by István Kertész Breakdown of academic impact, for papers by Daniel Gündel Breakdown of academic impact, for papers by Ruth Goldschmidt Breakdown of academic impact, for papers by Claudia Rosenbaum Breakdown of academic impact, for papers by Ole Tietz Breakdown of academic impact, for papers by Margaréta Lantow Breakdown of academic impact, for papers by Vikas V. Dukhande Breakdown of academic impact, for papers by Chunyang Jin
Rankless by CCL
2026